Skip to main content

Home/ Nutrition/ Group items tagged phytonadione

Rss Feed Group items tagged

Matti Narkia

Vitamin K and the Prevention of Fractures: Systematic Review and Meta-analysis of Rando... - 0 views

  •  
    Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Arch Intern Med. 2006 Jun 26;166(12):1256-61. Review. PMID: 16801507 Conclusions This systematic review suggests that supplementation with phytonadione and menaquinone-4 reduces bone loss. In the case of the latter, there is a strong effect on incident fractures among Japanese patients.
Matti Narkia

[Vitamin K2] [Clin Calcium. 2008] - PubMed result - 0 views

  •  
    [Vitamin K2] Ishida Y. Clin Calcium. 2008 Oct;18(10):1476-82. Review. Japanese. PMID: 18830045 "Vitamin K2 has been approved for the treatment of osteoporosis in Japan since 1995. Vitamin K2 treatment in osteoporosis has been shown to inhibit the occurrence of new bone fractures and to maintain BMD. The uniqueness of the prevention of bone fractures by vitamin K2 is that there has been no direct evidence of the relationship between increase of BMD and a decrease in the occurrence of bone fractures. A recent systematic review of seven Japanese randomized controlled trials by Cockayne has also shown that supplementation with phytonadione (Vitamin K1) and menaquinone (Vitamin K2) , particularly menaquinone-4, is associated with increased BMD and reduced fracture incidence. To confirm these results, a larger well design RCT using fractures as the primary endpoint is clearly needed."
1 - 2 of 2
Showing 20 items per page